Anti-IgE immunotherapy

· Resistentia Pharmaceuticals AB

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Anti-IgE immunotherapy, covering 2008-08-18 to 2008-08-18. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study of Anti-IgE Immunotherapy in Allergic Patients [Phase 2]